Albatroz Therapeutics is a pre-clinical stage biotechnology company with a mission to treat solid tumors and arthritic disorders that depend on extracellular matrix (ECM) remodeling.
TEAM
Frederic Bard
CEO & Scientific Founder |
Guy Heathers
CBO & Business Co-Founder |
Cheng-I Wang
Head of Antibody Development |
|
|
